Cumulative network meta-analyses, practice guidelines, and actual prescriptions for postmenopausal osteoporosis: a meta-epidemiological study

[1]  P. Bergmann.  Change in Bone Density and Reduction in Fracture Risk: A Meta‐Regression of Published Trials , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  Fares Alahdab,et al.  Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis. , 2019, The Journal of clinical endocrinology and metabolism.

[3]  J. Cauley,et al.  Change in Bone Density and Reduction in Fracture Risk: A Meta‐Regression of Published Trials , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  Tianjing Li,et al.  Cumulative network-meta-analyses, practice guidelines and actual prescriptions of drug treatments for postmenopausal osteoporosis: a study protocol for cumulative network meta-analyses and meta-epidemiological study , 2018, BMJ Open.

[5]  C. Friedman,et al.  Mind the Gap: Putting Evidence into Practice in the Era of Learning Health Systems , 2018, Journal of General Internal Medicine.

[6]  Isabelle Boutron,et al.  Misrepresentation and distortion of research in biomedical literature , 2018, Proceedings of the National Academy of Sciences.

[7]  Dimitris Mavridis,et al.  Living network meta-analysis compared with pairwise meta-analysis in comparative effectiveness research: empirical study , 2018, British Medical Journal.

[8]  E. Seoane-Vazquez,et al.  Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication , 2017, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[9]  Lara A Kahale,et al.  Living systematic reviews: 4. Living guideline recommendations. , 2017, Journal of clinical epidemiology.

[10]  A. de Laat,et al.  Network meta-analysis. , 2017, Journal of oral rehabilitation.

[11]  Zhen Wang,et al.  Guidelines for reporting meta-epidemiological methodology research , 2017, Evidence-Based Medicine.

[12]  Mohammed T Ansari,et al.  The GRADE Working Group clarifies the construct of certainty of evidence. , 2017, Journal of clinical epidemiology.

[13]  R. Landewé,et al.  Diagnosis, prognosis and classification of early arthritis: results of a systematic review informing the 2016 update of the EULAR recommendations for the management of early arthritis , 2017, RMD Open.

[14]  M. Dougados,et al.  2016 update of the EULAR recommendations for the management of early arthritis , 2016, Annals of the rheumatic diseases.

[15]  Jessica M Franklin,et al.  Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts. , 2016, JAMA internal medicine.

[16]  K. Dickersin,et al.  Network Meta-analysis for Clinical Practice Guidelines: A Case Study on First-Line Medical Therapies for Primary Open-Angle Glaucoma , 2016, Annals of Internal Medicine.

[17]  Anna Chaimani,et al.  Visualizing Assumptions and Results in Network Meta-analysis: The Network Graphs Package , 2015 .

[18]  Elizabeth Murray,et al.  Achieving change in primary care—causes of the evidence to practice gap: systematic reviews of reviews , 2015, Implementation Science.

[19]  Ian R. White,et al.  Network Meta-analysis , 2015 .

[20]  Steven Wooding,et al.  How long does biomedical research take? Studying the time taken between biomedical and health research and its translation into products, policy, and practice , 2015, Health Research Policy and Systems.

[21]  B. Dawson-Hughes,et al.  The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  M. Aapro,et al.  Bone health in cancer patients: ESMO Clinical Practice Guidelines. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  Anna Chaimani,et al.  Evaluating the Quality of Evidence from a Network Meta-Analysis , 2014, PloS one.

[24]  V. Fulgoni,et al.  Multivitamin/Mineral Supplement Contribution to Micronutrient Intakes in the United States, 2007–2010 , 2014, Journal of the American College of Nutrition.

[25]  Tari Turner,et al.  Living Systematic Reviews: An Emerging Opportunity to Narrow the Evidence-Practice Gap , 2014, PLoS medicine.

[26]  Panagiota Spyridonos,et al.  Graphical Tools for Network Meta-Analysis in STATA , 2013, PloS one.

[27]  L. Rodríguez-Mañas,et al.  Low calcium intake and inadequate vitamin D status in postmenopausal osteoporotic women , 2013, The Journal of Steroid Biochemistry and Molecular Biology.

[28]  P. Glasziou,et al.  Are systematic reviews up-to-date at the time of publication? , 2013, Systematic Reviews.

[29]  Dimitris Mavridis,et al.  Network meta‐analysis models to account for variability in treatment definitions: application to dose effects , 2013, Statistics in medicine.

[30]  M. Zodet,et al.  Implications of the Accuracy of MEPS Prescription Drug Data for Health Services Research , 2011, Inquiry : a journal of medical care organization, provision and financing.

[31]  Georgia Salanti,et al.  Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. , 2011, Journal of clinical epidemiology.

[32]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[33]  Alison M. MacLeod.  KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) , 2009 .

[34]  S. Blalock,et al.  Trends and determinants of prescription medication use for treatment of osteoporosis. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[35]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, PloS one.

[36]  C. Steiner,et al.  Sensitivity of Household Reported Medical Conditions in the Medical Expenditure Panel Survey , 2009, Medical care.

[37]  L. Markson,et al.  Impact of Recent Fracture on Health‐Related Quality of Life in Postmenopausal Women , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[38]  G. Lu,et al.  Assessing Evidence Inconsistency in Mixed Treatment Comparisons , 2006 .

[39]  J. Manson,et al.  Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society , 2006, Menopause.

[40]  G. Lu,et al.  Combination of direct and indirect evidence in mixed treatment comparisons , 2004, Statistics in medicine.

[41]  E. Balas,et al.  Managing Clinical Knowledge for Health Care Improvement , 2000, Yearbook of Medical Informatics.

[42]  R. Kampmeier.  The American College of Physicians , 1968, Journal of the Royal College of Physicians of London.

[43]  Rhiannon K Owen,et al.  Network meta-analysis: development of a three-level hierarchical modeling approach incorporating dose-related constraints. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[44]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration , 2013 .

[45]  J. Higgins.  Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .